Open access · CC-BY
via OpenAlex
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay
Life · 2024 · ▲ 26 citations
Abstract
The bidirectional relationship between type 2 diabetes and (non-alcoholic fatty liver disease) NAFLD is indicated by the higher prevalence and worse disease course of one condition in the presence of the other, but also by apparent beneficial effects observed in one, when the other is improved. This is partly explained by their belonging to a multisystemic disease that includes components of the metabolic syndrome and shared pathogenetic mechanisms. Throughout the progression of NAFLD to more advanced stages, complex systemic and local metabolic derangements are involved. During fibrogenesis, a significant metabolic reprogramming occurs in the hepatic stellate cells, hepatocytes, and immune cells, engaging carbohydrate and lipid pathways to support the high-energy-requiring processes. The natural history of NAFLD evolves in a variable and dynamic manner, probably due to the interaction of a variable number of modifiable (diet, physical exercise, microbiota composition, etc.) and non-modifiable (genetics, age, ethnicity, etc.) risk factors that may intervene concomitantly, or subsequently/intermittently in time. This may influence the risk (and rate) of fibrosis progression/regression. The recognition and control of the factors that determine a rapid progression of fibrosis (or its regression) are critical, as the fibrosis stages are associated with the risk of liver-related and all-cause mortality.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/life14020272
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Cernea, S. (2024). NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. <em>Life</em>. https://doi.org/10.3390/life14020272
Vancouver
Cernea S. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life. 2024. doi:10.3390/life14020272.
BibTeX
@article{simona2024NAFLDF,
title = {NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay},
author = {Simona Cernea},
journal = {Life},
year = {2024},
doi = {10.3390/life14020272},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrients 2020
Open access · CC-BY
You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review
Nutrients 2020
Open access · CC-BY
Beneficial Effects of Time-Restricted Eating on Metabolic Diseases: A Systemic Review and Meta-Analysis
Diabetes Care 2004
Open access · OA
Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes
Gastroenterology Research and Practice 2017
Open access · CC-BY
Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease
Frontiers in Physiology 2018
Open access · CC-BY
The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis
Foods 2024
Open access · CC-BY